Published in Transplantation on April 27, 2006
Laparoscopic live donor nephrectomy: Are ten cases per year enough to reach the quality standards? A report from a single small-volume transplant center. Surg Endosc (2009) 0.75
Need for a registry of living kidney donor outcomes. Transplantation (2006) 0.75
Perioperative mortality and long-term survival following live kidney donation. JAMA (2010) 7.34
Race and trust in the health care system. Public Health Rep (2003) 6.74
Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med (2010) 6.26
Association of race and age with survival among patients undergoing dialysis. JAMA (2011) 5.82
Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation (2002) 3.41
Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs. Med Care (2002) 3.37
Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients. Transplantation (2014) 2.26
Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant (2004) 2.22
Stem cell mobilization is life saving in an animal model of acute liver failure. Ann Surg (2010) 2.19
Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA (2005) 2.15
Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology (2011) 2.07
Determinants of willingness to donate living related and cadaveric organs: identifying opportunities for intervention. Transplantation (2002) 2.06
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation. Transplantation (2014) 2.00
Obesity impacts access to kidney transplantation. J Am Soc Nephrol (2007) 1.95
Candidacy for kidney transplantation of older adults. J Am Geriatr Soc (2012) 1.85
Center-level factors and racial disparities in living donor kidney transplantation. Am J Kidney Dis (2012) 1.82
Kidney paired donation and optimizing the use of live donor organs. JAMA (2005) 1.82
A nonsimultaneous, extended, altruistic-donor chain. N Engl J Med (2009) 1.81
Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients. Transplantation (2012) 1.78
"Big data" in the intensive care unit. Closing the data loop. Am J Respir Crit Care Med (2013) 1.76
Multi-detector row CT evaluation of living renal donors prior to laparoscopic nephrectomy. Radiographics (2004) 1.74
Utilization and outcomes of kidney paired donation in the United States. Transplantation (2008) 1.74
Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol (2004) 1.68
Age and comorbidities are effect modifiers of gender disparities in renal transplantation. J Am Soc Nephrol (2009) 1.64
Polyomavirus allograft nephropathy: sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant (2003) 1.64
Patient attitudes toward CDC high infectious risk donor kidney transplantation: inferences from focus groups. Clin Transplant (2011) 1.64
Laparoscopic live donor nephrectomy: trends in donor and recipient morbidity following 381 consecutive cases. Ann Surg (2004) 1.63
Concomitant surgery with laparoscopic live donor nephrectomy. Am J Transplant (2003) 1.62
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation (2008) 1.62
Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation. Transplantation (2014) 1.62
Live donor champion: finding live kidney donors by separating the advocate from the patient. Transplantation (2012) 1.60
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant (2003) 1.58
Prolonged waiting times for liver transplantation in obese patients. Ann Surg (2008) 1.57
Outcomes of ABO-incompatible kidney transplantation in the United States. Transplantation (2012) 1.55
Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation (2009) 1.54
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52
Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. Transplantation (2008) 1.52
Managing renal transplant ischemia reperfusion injury: novel therapies in the pipeline. Clin Transplant (2013) 1.51
Fatal and nonfatal hemorrhagic complications of living kidney donation. Ann Surg (2006) 1.49
Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg (2008) 1.49
Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation (2003) 1.47
Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol (2004) 1.46
Living kidney donors ages 70 and older: recipient and donor outcomes. Clin J Am Soc Nephrol (2011) 1.45
Cardiac tamponade in an orthotopic liver recipient with pulmonary hypertension. Crit Care Med (2002) 1.44
Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42
Effect of eliminating priority points for HLA-B matching on racial disparities in kidney transplant rates. Am J Kidney Dis (2011) 1.41
Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36
Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation (2008) 1.35
Promotion of altruistic donation. Transplantation (2009) 1.33
Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation (2005) 1.32
A comparison of populations served by kidney paired donation and list paired donation. Am J Transplant (2005) 1.32
Frailty and delayed graft function in kidney transplant recipients. Arch Surg (2012) 1.30
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Immunosuppression: practice and trends. Am J Transplant (2004) 1.28
The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion (2008) 1.27
The pathobiology of polyomavirus infection in man. Adv Exp Med Biol (2006) 1.27
Multidetector CT angiography for preoperative evaluation of living laparoscopic kidney donors. AJR Am J Roentgenol (2003) 1.26
Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation (2002) 1.23
Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis (2006) 1.23
Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol (2012) 1.21
Phylogenetic analysis of polyomavirus BK sequences. J Virol (2006) 1.19
Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother (2006) 1.18
ABO-incompatible kidney transplantation: current practice and the decade ahead. Curr Opin Organ Transplant (2010) 1.18
Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies. Transplantation (2014) 1.16
Impact of renal artery multiplicity on outcomes of renal donors and recipients in laparoscopic donor nephrectomy. Urology (2003) 1.15
Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols. Transplantation (2004) 1.15
Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation (2006) 1.14
Antibody-mediated rejection in kidney transplantation: a review. J Transplant (2012) 1.12
Quantitation of DNA of polyomaviruses BK and JC in human kidneys. J Infect Dis (2005) 1.12
Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol (2006) 1.12
The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl (2002) 1.11
Eculizumab and renal transplantation in a patient with CAPS. N Engl J Med (2010) 1.11
Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials. Liver Transpl (2008) 1.10
Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation (2003) 1.10
Transplanting the highly sensitized patient: trials and tribulations. Curr Opin Nephrol Hypertens (2013) 1.09
Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Hum Immunol (2009) 1.08
Single versus en bloc kidney transplantation from pediatric donors less than or equal to 15 kg. Transplantation (2008) 1.08
Pathogenesis and management of polyomavirus infection in transplant recipients. Clin Infect Dis (2002) 1.07
The combined organ effect: protection against rejection? Ann Surg (2008) 1.07
Kidney paired donation: fundamentals, limitations, and expansions. Am J Kidney Dis (2011) 1.06
Comorbid conditions in kidney transplantation: association with graft and patient survival. J Am Soc Nephrol (2005) 1.06
Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant (2004) 1.05
Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol (2005) 1.05
The general public's concerns about clinical risk in live kidney donation. Am J Transplant (2002) 1.05
C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol (2008) 1.04
Streamlining ABO antibody titrations for monitoring ABO-incompatible kidney transplants. Transfusion (2009) 1.04
ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant (2005) 1.04
Renal transplant in HIV-positive patients: long-term outcomes and risk factors for graft loss. Arch Surg (2009) 1.04
Early urethral (Foley) catheter removal positively affects length of stay after renal transplantation. Transplantation (2007) 1.03
Perturbation of thymocyte development in nonsense-mediated decay (NMD)-deficient mice. Proc Natl Acad Sci U S A (2011) 1.03
Whole body donation for medical science: a population-based study. Clin Anat (2004) 1.02